1-4 of 4
Adel Kardosh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In-Situ Vaccination Using Sting Agonists Combined with Immune-Modulating Antibodies to Treat Lymphoma

Adrienne Sallets, PhD, Adel Kardosh, Sophie Robinson, BS, Ronald Levy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4102.
https://doi.org/10.1182/blood.V130.Suppl_1.4102.4102
Published: 2017
Journal Articles

Examining the Heterogeneity of Follicular Lymphoma By Multi-Parameter Flow Cyotmetry in Previously Untreated Patients

Debra K Czerwinski, Steven R Long, MD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Adel Kardosh, MD PhD, Ami Okada, PhD, Sophie Robinson, Ronald Levy, MD
Journal: Blood
Blood (2016) 128 (22): 2947.
https://doi.org/10.1182/blood.V128.22.2947.2947
Published: 2016
Journal Articles

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors

Encouse B. Golden, Philip Y. Lam, Adel Kardosh, Kevin J. Gaffney, Enrique Cadenas, Stan G. Louie, Nicos A. Petasis, Thomas C. Chen, Axel H. Schönthal
Journal: Blood
Blood (2009) 113 (23): 5927–5937.
https://doi.org/10.1182/blood-2008-07-171389
Published: 2009
Journal Articles

Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non–COX-2 inhibitory analog of celecoxib

Adel Kardosh, Nathaniel Soriano, Yen-Ting Liu, Jasim Uddin, Nicos A. Petasis, Florence M. Hofman, Thomas C. Chen, Axel H. Schönthal
Journal: Blood
Blood (2005) 106 (13): 4330–4338.
https://doi.org/10.1182/blood-2005-07-2819
Published: 2005